1, CTX cyclophosphamide 200mg/strip iv or ivdrip 0, 9% NS water for injection Ready to use Be careful to drink more water, the drip rate should be 30~40 drops/div. Large doses should be hydrated diuretic, while is the use of uroprotective agents (mesna) to prevent hemorrhagic cystitis; use with caution in hepatic and renal impairment. 2, IFO isocyclophosphamide 1g/branch ivdrip Ringer 0, 9% NS Ready to use Urinary toxic reaction is serious, 2, 5g/m dissolved in saline or Ringer’s solution 500~1000ml to be dripped for 3~4 hours. It needs to be fully hydrated and detoxified with Mesna at the same time; minimize the simultaneous application of sedative, analgesic and anesthetic drugs to reduce neurological toxicity. Mesna Mesna 0,4/branches iv or ivdrip 0,9% NS ready to use Injected once at the same time of dropping isocyclophosphamide, and once at the 4th hour and 8th hour after dropping. 3.ADM Adriamycin 10mg/iv or ivdrip 0.9％ NS 5% GS ready to use Prevent leakage, extravasation may cause tissue ulceration and necrosis, preferably administered by central vein. Cardiac toxicity, cardiac monitoring should be performed during chemotherapy to avoid acute toxicity. Patients should be informed that urine can turn red. BPI epi-adriamycin 10mg/ivdrip 0,9% NS injection water ready to use Prevent leakage, extravasation may cause tissue ulceration and necrosis, preferably administered by central vein. Cardiotoxicity, cardiac monitoring should be performed during chemotherapy to avoid acute toxicity. Patients should be informed that urine can turn red. 4.THP Pyridoxine 10mg/ivdrip 5% GS can cause vascular pain and phlebitis when administered intravenously. Avoid dispensing with saline. 30~40 drops/min. 5. MMC mitomycin 2mg/iv or ivdrip 0.9% NS Ready-to-use Intravenous injection can cause vascular pain, phlebitis and thrombosis. Observe the injection site and slow down the injection speed as much as possible. Do not let the drug leak out of the blood vessels; monitor the blood changes because platelets and white blood cells will decrease, the former is especially obvious, there may be a tendency to bleed. 6.CBDCA Carboplatin 100mg/ ivdrip 5% GS 0.9% NS Now use liver and kidney function need to be monitored, bone marrow function has been significantly suppressed. Avoid direct sunlight during infusion. 7.DDP Cisplatin 10mg/ ivdrip 0.9％ NS Now used liver and kidney function needs to be monitored, the drug should be protected from light, 500ml should be finished within two hours. The dose of cisplatin must be hydrated and diuretic according to the dose of cisplatin, and the amount should be recorded. Nausea and vomiting should be prevented and treated promptly. Pay attention to whether the patient has tinnitus, and stop the drug in time for observation. 8.Platinum oxalate Ai Heng 50mg/strip ivdrip 5% GS ready to use, not with chlorine compounds, before and after its infusion should be infused with glucose solution. 250~500ml of 5% GS solution should be infused for 2~6 hours. It is strictly forbidden to wash with cold water and eat cold food; it is forbidden to infuse with alkaline drugs or alkaline solutions; it should avoid contact with aluminum products when configuring the solution and infusion. 9.MTX Methotrexate 5mg/branch 1g/branch iv or ivdrip or im 0,9% NS 5% GS ready to use Prevent leakage, can cause tissue ulceration, a use of more than 5g intravenous injection to 6 hours, less than 5g to 30~40 drops/minute, large doses require CF detoxification. When combined with weak acidic drugs, such as aspirin or sulfonamides, the toxicity can be increased; the blood picture and liver and kidney function should be closely observed during treatment; when VCR and MTX are combined, VCR should be used first to stop the flow of MTX from the cells, which can improve the efficacy; MTX first and then 5-FU can increase cell killing; MTX first and then L-ASP can reduce the cytotoxicity of MTX. 10.5-Fu Fluorouracil 250mg/iv or ivdrip 0.9％ NS 5% GS Ready-to-use 5-FU is metabolized and decomposed by liver and excreted by kidney and respiratory tract, liver and kidney function should be monitored before and after treatment; monitor urine volume so as not to exceed 1500ml per day in adults to avoid accumulative toxicity. Toxic side effects vary in severity depending on the route of administration. If given orally, the gastrointestinal reactions are heavy; if given intravenously, all reactions are heavy; if given continuously for more than 4~6 hours, the efficacy is better and the side effects are lighter. CF Calcium folinic acid 100mg/stem 50mg/stem iv or ivdrip or im 0,9% NS 5% GS ready to use This product should not be used together with folic acid antagonists such as methotrexate. In case of methotrexate overdose, 10~12mg of this product can be injected intramuscularly every 6 hours for detoxification. 11.HCPT Hydroxycamptothecin 2mg/iv or ivdrip 0,9% NS should be injected slowly, fast titration may cause arrhythmia. Patients should be encouraged to drink more water during use to reduce bladder irritation. 12.taxol 30 mg/ivdrip 0.9％ NS 5% GS ready to use. Use first than Adriamycin, then use Adriamycin 3 hours after drip, 500ml liquid for not less than 3 hours, pay attention to allergic reaction, prepare for resuscitation when using the drug. Use special tubes, do not touch PVC plastic instruments and equipment. Pay attention to monitoring changes in vital signs during drug administration. dacetaxol Tysotil 20mg/stem 80mg/stem ivdrip 0,9% NS ready to use Every 75mg/O will be dripped in 1 hour. Pay attention to allergic reactions and be prepared to resuscitate when using the drug. Do not shake vigorously when dispensing. To prevent fluid retention, corticosteroids should be taken in advance. 13.GEM Jianze 1g/ 200mg/ ivdrip 0.9％ NS Ready to use 100ml or 250ml of rehydration solution to be dripped within 30~40 minutes. Prolong the drug drip time and increase the frequency of drug administration can increase drug toxicity. 14.VCR Vincristine 1mg/branch iv 0.9％ NS water for injection ready to use Only for intravenous injection, exudation may cause local necrosis; prevent the drug from splashing into eyes; avoid light when using; observe whether there are signs of intestinal obstruction such as constipation and abdominal distension. 15, VDS Vincristine or Ciamisil 4mg/iv or ivdrip 0, 9% NS Water for injection Ready to use Must be dissolved in saline and infused intravenously within a short period of time, i.e. 15-20 minutes, and flush the tube with saline. Monitor the blood neurotoxic reaction; preferably use central vein injection; avoid light; keep the stool open. 16.NVB Norviben/Gainor 10mg/ivdrip 0,9% NS ready to use Must be dissolved in saline and infused intravenously within 15~20 minutes and flushed with saline. It is preferable to use central venous infusion; monitor the blood picture and prevent infection; keep the stool open. 17.Vp16 Adequanoside 100mg/iv or ivdrip 0,9% NS ready to use Avoid light VM26 Ghostoside 50mg/ivdrip 0,9% NS 5% GS ready to use The toxicity of this product is myelosuppression manifested as thrombocytopenia. When administering the drug, be careful to avoid tissue necrosis due to extravasation and monitor vital signs within 30 minutes. 30~40 drops/min. Use with caution in patients with hepatic or renal impairment or tumors that have invaded the bone marrow. Vital signs. The drip rate should not be too fast and should be over 30 minutes to avoid hypotension. Avoid conception at the time of drug administration. 18.herceptin 440mg/ ivdrip 0,9% NS is used to dilute 440mg of herceptin with 20ml of sterile solution delivered, each time 250ml of 0,9% NS is added to 110mg of herceptin dilution for half an hour (90 minutes for first use). The leftover solution must be kept sterile and sealed at 2-8°C. Do not shake vigorously when dispensing. 19.DTIC Azulfiram ivdrip 5% GS ready to use Decompose with heat, unstable to light and acid, avoid light when infusing; avoid local damage by extravasation. Intravenous drip 30~60 minutes.